EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Aortic valve replacement and mortality in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy

Jason H Wasfy, Muhammad Etiwy, Yunong Zhao, Sarah K Gustus, Adam N Berman, Chiara Fraccaro, Nicole Karam iD, Meagan M Wasfy, John Hsu, Michael H Picard iD

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf211 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Jason H Wasfy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Vascular Institute and Department of Medicine, Mass General Brigham, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts, 02138,…. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Hypertrophy, Left Ventricular, Heart Valve Prosthesis Implantation, Aortic Valve. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Massachusetts General Hospital Executive Committee on Research, Clem family to the Massachusetts General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Indications for aortic valve replacement (AVR) in severe asymptomatic aortic stenosis (AS) differ for individuals with normal versus low or decreasing left ventricular ejection fraction (LVEF). Conceptually, the development of left ventricular hypertrophy (LVH) could also indicate ventricular injury and potential need for earlier AVR. METHODS Initially, 1 232 492 echocardiography reports from 12 hospitals were identified; then previously validated, open-source natural language processing modules were applied to identify aortic gradients, LVEF, and the presence of LVH. These reports were linked to mortality data, key comorbidities, and date of any AVR. We then performed physician chart reviews, identified asymptomatic individuals with normal flow severe AS, LVEF ≥ 55%, and LVH, and confirmed key clinical data manually. To assess the association between AVR and mortality, Cox proportional hazards models considering treatment status (i.e., AVR or not considered as a time-dependent covariate) were used with the index echocardiogram as time zero. RESULTS After application of eligibility criteria, 607 unique, confirmed asymptomatic individuals remained for the primary analysis. After adjustment, and accounting for the time-dependence of AVR, AVR was associated with reduced mortality (hazard ratio 0.37; 95% confidence interval 0.25–0.55, P < 0.0001). CONCLUSIONS AVR was associated with reduced mortality for patients with severe asymptomatic AS, preserved LVEF, and LVH. This is the largest known analysis of aortic valve replacement outcomes in individuals with severe aortic stenosis and left ventricular hypertrophy. As clinical guidelines for intervention in asymptomatic severe aortic stenosis expand, left ventricular hypertrophy is easier to assess than myocardial fibrosis and may be a useful marker for patients who need to be prioritized. These results raise the potential of more proactive AVR in individuals with LVH, even among asymptomatic individuals with normal LVEF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisHypertrophy, Left VentricularHeart Valve Prosthesis ImplantationAortic ValveHumansMaleFemaleAgedAged, 80 and overEchocardiographyAsymptomatic DiseasesMiddle AgedRetrospective StudiesSeverity of Illness Index

Stichwörter der Autor:innen

Aortic stenosisLeft ventricular hypertrophySurvival

Autor:innen und Institutionen

  • Heart and Vascular Institute and Department of Medicine, Mass General Brigham, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts, 02138, USA.
  • Dartmouth Geisel School of Medicine, 1 Rope Ferry Rd, Hanover, New Hampshire, 03755, USA.
  • New York University School of Medicine, 550 First Avenue, New York, New York, 10016, USA.
  • Università degli Studi di Padova, Padova, Via 8 Febbraio 1848, 2, Padova PD, Italy.
  • Hôpital Européen Georges-Pompidou et Université de Paris, Paris, 20 Rue Leblanc, Paris 75015, France.

ORCID-Profile: Nicole Karam, Michael H Picard

Förderung

  • NHLBI NIH HHS
  • Massachusetts General Hospital Executive Committee on Research
  • Clem family to the Massachusetts General Hospital
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Wasfy, J. H., Etiwy, M., Zhao, Y., Gustus, S. K., Berman, A. N., Fraccaro, C., Karam, N., Wasfy, M. M., Hsu, J., & Picard, M. H. (2025). Aortic valve replacement and mortality in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf211

Vancouver

Wasfy JH, Etiwy M, Zhao Y, Gustus SK, Berman AN, Fraccaro C, et al. Aortic valve replacement and mortality in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf211

BibTeX
@article{Wasfy2025,
  author = {Wasfy, Jason H and Etiwy, Muhammad and Zhao, Yunong and Gustus, Sarah K and Berman, Adam N and Fraccaro, Chiara and Karam, Nicole and Wasfy, Meagan M and Hsu, John and Picard, Michael H},
  title = {Aortic valve replacement and mortality in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf211}
}
Kostenlos starten →